The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Apolipoprotein E: Structure-Function Relationships
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We identified Gly145Asp and Arg154Cys in the same J o u r n a l P r e -p r o o f region (amino acids ~ 148 to 168) [47]”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Variants predicted by models to be deleterious or being located near or in the receptor binding region (amino acids ~ 148 to 168) [47] could be suspected to pose ε2-like qualities.”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Additional support comes from the present data, where Gly145Asp and Arg154Cys are located in the receptor binding region (amino acids ≈148 to 168) 28 and display a phenotype similar to the ɛ2‐defining Arg176Cys residue with high apoE levels and seemingly low risk of dementia (no events).”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“Val254Glu and Arg269Gly are located in the lipid‐binding carboxyl‐terminal domain (amino acids ≈243 to 317). 28 , 42”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“However, the receptor-binding sites (AA136-150) for lipoprotein receptors such as the low-density lipoprotein receptor (LDLR), lipoprotein-related receptor 1 (LRP1), and heparan sulfate proteoglycans (HSPGs) are located in a region conserved between species (Fig. 1a) [11–14].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“Notably, an HSPG and LDLR binding site in the APOE sequence is conserved in mice (blue boxed area, AA136-150), including arginine 136, which is replaced by serine in the Christchurch (Ch) variant [12, 39].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“However, mAPOE and hAPOE have a conserved LDLR and HSPG binding motif between AA136 to 150 (human numbering) [11, 12, 39], which includes the R136S Christchurch variant.”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“The mature apoE protein consists of 299 amino acids and an 18amino acid signal peptide is removed post-translationally [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The APOE gene is located on chromosome 19 and consists of four exons [28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Lipid-free apoE consists of two domains connected by a “hinge region”: the amino-terminal domain (amino acids 1 to 191) contains the receptor-binding function and the carboxyl-terminal domain (~amino acids 225 to 299) contains the lipid-binding function [28,33].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The low density lipoprotein (LDL) receptor binding region is situated in helix four between amino acids 136 and 150 [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE2 exhibits a lower affinity to the LDL receptor compared to apoE3: ~1% of the binding activity of apoE3 and apoE4 [28,36].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Furthermore, apoE and apoB share the sequence with highest affinity for arterial proteoglycans, a key phenomenon for lipoprotein deposition in the arterial wall [28,63].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE contains two independently folded functional domains; these are a 22-kDa N-terminal domain (residues 1–191) and a 10-kDa C-terminal domain (residues 216–299) linked by a hinge region (18, 19).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [18]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Prediction of protein conformation
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a002 · Cited by 3,309
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Research works printed but not linked: 17
- Cassel, 1984, Atherosclerosis (Shannon, Irel.), 52, 203
- Hallman, 1991, Am. J. Hum. Genet., 49, 338
- Havel, 1989, 1, 1129
- Koizumi, 1985, Antherosclerosis (Shannon, Irel.), 58, 175
- Landis, 1987, Am. J. Physiol., 252, G805
- Lund-Katz, 1993, J. Biol. Chem.
- Mahley, 1983, Arch. Pathol. Lab. Med., 107, 393
- Mahley, 1989, 1, 1195
- Mahley, 1983, 4, 151
- Mahley, 1977, Am. J. Pathol., 87, 205
- Mahley, 1983, Biochim. Biophys. Acta., 737, 197, 10.1016/0304-4157(83)90001-1 · DOI
- Mahley, 1989, 1, 1195
- Phillips, 1986, 128, 387
- Srinivasan, 1972, Atherosclerosis (Shannon, Irel.), 16, 95
- Utermann, 1980, Am. J. Hum. Genet., 32, 339
- Weisgraber, 1983, 4, 103
- Yamamura, 1984, Atherosclerosis (Shannon, Irel.), 50, 159
Cited by
Sorted by citations
Items 201–300 of 828
Gao, J., Wang, H., Sheng, H., Lynch, J., Warner, D. S., Durham, L., Vitek, M. P., & Laskowitz, D. T. (2006) · Neurocritical Care · doi:10.1385/ncc:4:1:025 · Cited by 82
Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases.
Huang, Y. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833af368 · Cited by 82
Laskowitz, D. T., Fillit, H. M., Yeung, N., Toku, K., & Vitek, M. P. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00680.x · Cited by 82
Poupard, G. P., André, M., Durliat, M., Ballagny, C., Bœuf, G., & Babin, P. J. (2000) · Cell and Tissue Research · doi:10.1007/s004419900158 · Cited by 81
Acharya, P., Segall, M. L., Zaiou, M., Morrow, J., Weisgraber, K. H., Phillips, M. C., Lund-Katz, S., & Snow, J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00263-9 · Cited by 82
Self-citationDifferential binding of triglyceride-rich lipoproteins to lipoprotein lipase
Xiang, S., Cianflone, K., Kalant, D., & Sniderman, A. D. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33411-8 · Cited by 81
Are men carrying the apolipoprotein ε4- or ε2 allele less fertile than ε3ε3 genotypes?
Gerdes, L. U., Gerdes, C., HANSEN, P. S., Klausen, I. C., & Færgeman, O. (1996) · Human Genetics · doi:10.1007/s004390050200 · Cited by 81
Xu, Q., Brecht, W. J., Weisgraber, K. H., Mahley, R. W., & Huang, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311256200 · Cited by 80
Self-citationPalm Tocotrienols Protect ApoE +/− Mice from Diet-Induced Atheroma Formation
Black, T. M., Wang, P., Maeda, N., & Coleman, R. (2000) · Journal of Nutrition · doi:10.1093/jn/130.10.2420 · Cited by 80
Fisher, C. A., Narayanaswami, V., & Ryan, R. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002643200 · Cited by 78
Narayanaswami, V., Maiorano, J. N., Dhanasekaran, P., Ryan, R. O., Phillips, M. C., Lund‐Katz, S., & Davidson, W. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313318200 · Cited by 77
Zaiou, M., Arnold, K. S., Newhouse, Y. M., Innerarity, T. L., Weisgraber, K. H., Segall, M. L., Phillips, M. C., & Lund‐Katz, S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32014-9 · Cited by 77
Self-citationEffect of ApoE Genotype on Response to Donepezil in Patients with Alzheimer’s Disease
Choi, S. H., Kim, S., Na, H. R., Kim, B., Yang, D. W., Kwon, J. C., & Park, M. Y. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000124752 · Cited by 79
Liu, M., Kuhel, D. G., Shen, L., Hui, D. Y., & Woods, S. C. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00219.2012 · Cited by 82
Lõokene, A., Savonen, R., & Olivecrona, G. (1997) · Biochemistry · doi:10.1021/bi962699k · Cited by 77
Monnot, M. J., Babin, P. J., Poleo, G. A., Andre, M., Laforest, L., Ballagny, C., & Akimenko, M. (1999) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199903)214:3 · Cited by 77
Miwa, Y., Mitsuzumi, H., SUNAYAMA, T., Yamada, M., OKADA, K., Kubota, M., Chaen, H., Mishima, Y., & Kibata, M. (2005) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.51.460 · Cited by 76
Apolipoprotein E4 domain interaction: Synaptic and cognitive deficits in mice
Zhong, N., Scearce-Levie, K. A., Ramaswamy, G., & Weisgraber, K. H. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.01.006 · Cited by 77
Self-citationDifferential oxidation of apolipoprotein E isoforms and interaction with phospholipids
Jolivalt, C. G., Leininger‐Muller, B., Bertrand, P., Herber, R., Christen, Y., & Siest, G. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00232-4 · Cited by 76
Apolipoprotein E Binds to and Potentiates the Biological Activity of Ciliary Neurotrophic Factor
Gutman, C. R., Strittmatter, W. J., Weisgraber, K. H., & Matthew, W. D. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-16-06114.1997 · Cited by 74
Self-citationHarnessing a Physiologic Mechanism for siRNA Delivery With Mimetic Lipoprotein Particles
Nakayama, T., Butler, J. S., Sehgal, A., Severgnini, M., Racie, T., Sharman, J., Ding, F., Shulga‐Morskaya, S., Brodsky, J., Tchangov, L., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.33 · Cited by 75
Gau, B., Garai, K., Frieden, C., & Gross, M. L. (2011) · Biochemistry · doi:10.1021/bi200911c · Cited by 74
Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells
Sacre, S. M., Stannard, A. K., & Owen, J. S. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00261-8 · Cited by 73
Li, H., Dhanasekaran, P., Alexander, E. T., Rader, D. J., Phillips, M. C., & Lund‐Katz, S. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301193 · Cited by 73
Lewandowski, C. T., Maldonado Weng, J., & LaDu, M. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104811 · Cited by 72
Lipids in Amyloid-β Processing, Aggregation, and Toxicity
Morgado, I., & Garvey, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17344-3_3 · Cited by 72
Aono, M., Bennett, E. R., Kim, K. S., Lynch, J., Myers, J., Pearlstein, R. D., Warner, D. S., & Laskowitz, D. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00709-1 · Cited by 72
Gómez‐Coronado, D., Álvarez, J. J., Bueno, A. E., Olmos, J. M., Herrera, E., & Lasunción, M. A. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00168-9 · Cited by 71
Bien-Ly, N., Andrews-Zwilling, Y., Xu, Q., Bernardo, A., Wang, C., & Huang, Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018381108 · Cited by 71
Thuahnai, S. T., Lund‐Katz, S., Anantharamaiah, G. M., Williams, D. L., & Phillips, M. C. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200429-jlr200 · Cited by 71
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis
TOMKIN, G. H., & Owens, D. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.179 · Cited by 71
Zhang, Z., Xin, X., Liu, C., Liu, Y., Duan, H., Qi, L., Zhang, Y., Zhao, H., Chen, L., Jin, M., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01097-8 · Cited by 70
Talwar, P., Sinha, J., Grover, S., Rawat, C., Kushwaha, S. S., Agarwal, R., Taneja, V., & Kukreti, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9390-0 · Cited by 71
An optimized negative-staining protocol of electron microscopy for apoE4•POPC lipoprotein
Zhang, L., Song, J., Newhouse, Y. M., Zhang, S., Weisgraber, K. H., & Ren, G. (2009) · Journal of Lipid Research · doi:10.1194/jlr.d002493 · Cited by 65
Self-citationHigh carbohydrate diets and Alzheimer's disease
Henderson, S. T. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.11.028 · Cited by 72
The role of apolipoprotein E in lipid metabolism in the central nervous system
Han, X. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4009-z · Cited by 69
The apolipoprotein E polymorphism in Greenland Inuit in its global perspective
Gerdes, L. U., Gerdes, C., HANSEN, P. S., Klausen, I. C., Færgeman, O., & Dyerberg, J. (1996) · Human Genetics · doi:10.1007/s004390050257 · Cited by 69
Kariv-Inbal, Z., Yacobson, S., Berkecz, R., Péter, M., Janáky, T., Lütjohann, D., Broersen, L. M., Hartmann, T., & Michaelson, D. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111265 · Cited by 70
Effect of Arginine 172 on the Binding of Apolipoprotein E to the Low Density Lipoprotein Receptor
Morrow, J. A., Arnold, K. S., Dong, J., Balestra, M. E., Innerarity, T. L., & Weisgraber, K. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2576 · Cited by 67
Self-citationFisher, C. A., Abdul‐Aziz, D., & Blacklow, S. C. (2004) · Biochemistry · doi:10.1021/bi035529y · Cited by 69
Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia
Cutler, R. G., Haughey, N. J., Tammara, A., McArthur, J. C., Nath, A., Reid, R., Vargas, D. L., Pardo, C. A., & Mattson, M. P. (2004) · Neurology · doi:10.1212/01.wnl.0000134662.19883.06 · Cited by 67
The helix bundle: A reversible lipid binding motif
Narayanaswami, V., Kiss, R. S., & Weers, P. M. M. (2009) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2009.09.009 · Cited by 69
Chouinard‐Watkins, R., & Plourde, M. (2014) · Nutrients · doi:10.3390/nu6104452 · Cited by 73
Klein, R. C., Mace, B. E., Moore, S. D., & Sullivan, P. M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.027 · Cited by 67
Alzheimer’s Disease Risk Genes and Lipid Regulators
Gaamouch, F. E., Jing, P., Xia, J., & Cai, D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160169 · Cited by 67
Narayanaswami, V., Wang, J., Kay, C. M., Scraba, D. G., & Ryan, R. O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26855 · Cited by 68
Müller, W. S., Meske, V., Berlin, K., Scharnagl, H., März, W., & Ohm, T. G. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00190.x · Cited by 67
Elimova, E. C., Kisilevsky, R., Szarek, W. A., & Ancsin, J. B. (2004) · The FASEB Journal · doi:10.1096/fj.03-1436fje · Cited by 67
Chou, C.-Y., Lin, Y.-L., Huang, Y.-C., Sheu, S.-Y., Lin, T.-H., Tsay, H.-J., Chang, G.-G., & Shiao, M.-S. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.046813 · Cited by 66
The Interaction of Amyloid-β with ApoE
Carter, D. B. (2005) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/0-387-23226-5_13 · Cited by 68
Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes
Mamotte, C. D. S., Sturm, M., Foo, J. I., BOCKXMEER, F. M. V., & Taylor, R. R. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.3.e553 · Cited by 66
Apolipoprotein E Polymorphisms and Concentration in Chronic Diseases and Drug Responses
Siest, G., Bertrand, P., Herbeth, B., Vincent‐Viry, M., Schiele, F., Sass, C., & Visvikis‐Siest, S. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.122 · Cited by 65
Functional Aspects of Redox Control During Neuroinflammation
Rosales‐Corral, S., Reiter, R. J., Tan, D., Ortiz, G. G., & López-Armas, G. D. C. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2629 · Cited by 66
Wang, H., Durham, L., Dawson, H. N., Song, P., Warner, D. S., Sullivan, P. M., Vitek, M. P., & Laskowitz, D. T. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.017 · Cited by 65
Molecular Mechanism of Apolipoprotein E Binding to Lipoprotein Particles
Nguyen, D., Dhanasekaran, P., Phillips, M. C., & Lund‐Katz, S. (2009) · Biochemistry · doi:10.1021/bi9000694 · Cited by 66
Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice
Weng, J. M., Parikh, I. J., Naqib, A. D., York, J. M., Green, S. J., Estus, S., & LaDu, M. J. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0352-2 · Cited by 65
APOE and dementia – resequencing and genotyping in 105,597 individuals
Rasmussen, K. L., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12165 · Cited by 64
Chasman, D. I., Kozłowski, P., Zee, R. Y. L., Kwiatkowski, D. J., & Ridker, P. M. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364289 · Cited by 65
Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function.
Teter, B., Xu, P., Gilbert, J. R., Roses, A. D., Galasko, D., & Cole, G. M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10221 · Cited by 74
Apolipoprotein E Attenuates β‐Amyloid‐Induced Astrocyte Activation
Hu, J., LaDu, M. J., & Van Eldik, L. J. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041626.x · Cited by 52
Burgos, J. S., Ramírez, C. D., Sastre, I., Bullido, M. J., & Valdivieso, F. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.12394-12398.2002 · Cited by 62
Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases.
Shajith Anoop, S., Misra, A., Meena, K., & Luthra, K. (2010) · PubMed · Cited by 60
Apolipoprotein E and viral infection: Risks and Mechanisms
Chen, F., Ke, Q., Wei, W., Cui, L., & Wang, Y. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.07.031 · Cited by 60
All-trans-retinoic acid nanodisks
Redmond, K. A., Nguyen, T.-S., & Ryan, R. O. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.02.033 · Cited by 60
A Role for Astrocytes in the Central Control of Metabolism
Yi, C., Habegger, K. M., Chowen, J. A., Stern, J. E., & Tschöp, M. H. (2011) · Neuroendocrinology · doi:10.1159/000324888 · Cited by 61
Lipids and the pathogenesis of Alzheimer's disease: Is there a link?
Mielke, M. M., & Lyketsos, C. G. (2006) · International Review of Psychiatry · doi:10.1080/09540260600583007 · Cited by 61
Apolipoprotein E and Alzheimer's Disease: A Review of Recent Studies
Higgins, G. A., Large, C. H., Rupniak, H. T., & Barnes, J. C. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00420-0 · Cited by 58
Lipid Association-induced N- and C-terminal Domain Reorganization in Human Apolipoprotein E3
Narayanaswami, V., Szeto, S. S. W., & Ryan, R. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102953200 · Cited by 59
Pocivavsek, A., MIKHAILENKO, I. A., Strickland, D. K., & Rebeck, G. W. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.06.010 · Cited by 63
Apolipoprotein E and Neurological Disease: Therapeutic Potential and Pharmacogenomic Interactions
Laskowitz, D. T., & Vitek, M. P. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.8.959 · Cited by 58
Activated retinal glia promote neurite outgrowth of retinal ganglion cells via apolipoprotein E
Lorber, B., Berry, M., Douglas, M. R., Nakazawa, T., & Logan, A. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22095 · Cited by 60
Chetty, P. S., Mayne, L., Lund-Katz, S., Englander, S. W., & Phillips, M. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617523114 · Cited by 58
Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E
Weisgraber, K. H., Pitas, R. E., & Mahley, R. W. (1994) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(94)90212-7 · Cited by 58
Self-citationApoE-Dependent Plasticity in Alzheimer's Disease
Teter, B. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:167 · Cited by 59
DeMattos, R. B. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:255 · Cited by 55
Saito, H., Minamida, T., Arimoto, I., Handa, T., & Miyajima, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15515 · Cited by 57
Interaction with Amyloid β Peptide Compromises the Lipid Binding Function of Apolipoprotein E
Tamamizu‐Kato, S., Cohen, J. K., Drake, C. B., Kosaraju, M. G., Drury, J., & Narayanaswami, V. (2008) · Biochemistry · doi:10.1021/bi702097s · Cited by 56
The Effect of Dietary Fat on LDL Size Is Influenced by Apolipoprotein E Genotype in Healthy Subjects
Moreno, J. A., Pérez‐Jiménez, F., Marı́n, C., Gómez, P., Pérez‐Martínez, P., Moreno‐Luna, R., Bellido, C., Fuentes, F. J., & López‐Miranda, J. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2517 · Cited by 57
Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions
Arimoto, I., Saito, H., Kawashima, Y., Miyajima, K., & Handa, T. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34210-3 · Cited by 57
Arai, H., Kashiwagi, S., Nagasaka, Y., Uchida, K., Hoshii, Y., & Nakamura, K. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1222 · Cited by 57
Yamauchi, Y., Deguchi, N., Takagi, C., Tanaka, M., Dhanasekaran, P., Nakano, M., Handa, T., Phillips, M. C., Lund-Katz, S., & Saito, H. (2008) · Biochemistry · doi:10.1021/bi8003999 · Cited by 53
Apolipoprotein E•dipalmitoylphosphatidylcholine particles are ellipsoidal in solution
Peters-Libeu, C. A., Newhouse, Y. M., Hall, S. C., Witkowska, H. E., & Weisgraber, K. H. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600545-jlr200 · Cited by 54
Self-citationWang, J., Gagné, S. M., Sykes, B. D., & Ryan, R. O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17912 · Cited by 56
Central nervous system lipoproteins in Alzheimer's disease.
Montine, T. J., Montine, K. S., & Swift, L. L. (1997) · Europe PMC (PubMed Central) · Cited by 56
Metabolic disorder in Alzheimer’s disease
Poddar, M. K., Banerjee, S., Chakraborty, A., & Dutta, D. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00673-z · Cited by 58
Cui, C., Zhao, W., Chen, J., Wang, J., & Li, Q. (2006) · Protein Expression and Purification · doi:10.1016/j.pep.2006.05.019 · Cited by 56
Laskowitz, D. T., Wang, H., Chen, T., Lubkin, D. T., Cantillana, V., Tu, T. M., Kernagis, D., Zhou, G., Macy, G., Kolls, B. J., et al. (2017) · Scientific Reports · doi:10.1038/srep46461 · Cited by 55
Absence of central cholinergic deficits in ApoE knockout mice
Anderson, R., & Higgins, G. A. (1997) · Psychopharmacology · doi:10.1007/s002130050329 · Cited by 55
Analysis of Association at Single Nucleotide Polymorphisms in the APOE Region
Martin, E. R., Gilbert, J. R., Lai, E., Riley, J., Rogala, A. R., Slotterbeck, B. D., Sipe, C. A., Grubber, J. M., Warren, L. L., Conneally, P. M., et al. (2000) · Genomics · doi:10.1006/geno.1999.6057 · Cited by 55
Sakamoto, T., Tanaka, M., Vedhachalam, C., Nickel, M., Nguyen, D., Dhanasekaran, P., Phillips, M. C., Lund-Katz, S., & Saito, H. (2008) · Biochemistry · doi:10.1021/bi701923h · Cited by 54
The Role of Apolipoprotein E in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis
Zhang, H., Wu, J., & Zhu, J. (2010) · BioMed Research International · doi:10.1155/2010/357412 · Cited by 57
Apolipoprotein E Protects against NMDA Excitotoxicity
Aono, M., Lee, Y., Grant, E. R., Zivin, R. A., Pearlstein, R. D., Warner, D. S., Bennett, E. R., & Laskowitz, D. T. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0541 · Cited by 54
Effects of Lipid Interaction on the Lysine Microenvironments in Apolipoprotein E
Lund‐Katz, S., Zaiou, M., Wehrli, S. L., Dhanasekaran, P., Baldwin, F., Weisgraber, K. H., & Phillips, M. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005265200 · Cited by 54
Self-citationApolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases
Mahley, R. W. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.255695 · Cited by 53
Apolipoprotein E isoform‐specific binding to the low‐density lipoprotein receptor
Yamamoto, T., Choi, H. W., & Ryan, R. O. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2007.09.005 · Cited by 59
Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease
Bales, K. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.005 · Cited by 58
A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy
Ando, M., Sasaki, J., Hua, H., Matsunaga, A., Uchida, K., Jou, K., Oikawa, S., Saito, T., & Nihei, H. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00677.x · Cited by 53
Goedert, M., Strittmatter, W. J., & Roses, A. D. (1994) · Nature · doi:10.1038/372045a0 · Cited by 54
Interleukin-1 induces major phenotypic changes in human skin microvascular endothelial cells
Romero, L. I., Zhang, D.-N., Herron, G. S., & Karasek, M. A. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199710)173:1 · Cited by 88
Genetic Influences in Traumatic Brain Injury
Laskowitz, D., & Grant, G. A. (2015) · CRC Press eBooks · doi:10.1201/b18959-14 · Cited by 54
Metadata
- Authors
- Weisgraber, K. H.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Weisgraber, Karl H.
- Venue
- Advances in Protein Chemistry
- Publisher
- Elsevier
- Published
- 1994
- Volume
- 45
- Pages
- 249-302
- ISSN
- 0065-3233 (ISSN-L)
- OpenAlex
- W98152484
- Cited by
- 830
- References
- 194
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 14 · 2023: 17 · 2022: 12 · 2021: 20 · 2020: 12 · 2019: 13 · 2018: 14 · 2017: 20 · 2016: 18 · 2015: 15 · 2014: 18 · 2013: 23 · 2012: 26
- FWCI
- 89.45
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in protein chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-41633, P01HL041633)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E, lipoprotein metabolism, apolipoprotein structure, APOE isoforms, lipid transfer proteins, lipoprotein receptors, triglyceride-rich lipoproteins, reverse cholesterol transport, lipolysis, serum lipoproteins
- MeSH terms
- Amino Acid Sequence, Animals, Apolipoproteins E, Humans, Molecular Sequence Data, Protein Conformation, Structure-Activity Relationship, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
